Multiple sclerosis 2024: Clinical trials for progressive multiple sclerosis: progress, new lessons learned, and remaining challenges Chataway et al. The Lancet Neurology

Executive Summary Multiple sclerosis is an immune-mediated disease of the central nervous system and a leading cause of neurological disability. Considerable progress in imaging techniques and fluid biomarkers have enhanced our understanding of MS, improving diagnostic, prognostic, and treatment monitoring tools. However, understanding the different clinical manifestations, timely diagnosis and treatment success remains a critical unmet need. https://www.thelancet.com/series/multiple-sclerosis-2024?dgcid=hubspot_update_feature_infocusbrainhealth_lanepemultiplesclerosis24&utm_campaign=update-lanepe&utm_medium=email&_hsenc=p2ANqtz--lf7Lfvy6QVrDoMswBrxjtxJvxRj8Hlfggxm8jOX9uYMQpwOrYDASmy05XGFaqr8m-DSmUqfX8hGMywHbHuIf5GQMpKQ&_hsmi=325079447&utm_content=325001241&utm_source=hs_email